A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions
NCT00865761
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Alprazolam 3 mg Extended Release Tablets, single dose
DRUG:
XANAX XR® 3 mg tablets, single dose
Sponsor
Actavis Inc.